| (19) |
 |
|
(11) |
EP 2 093 565 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
09.09.2009 Bulletin 2009/37 |
| (43) |
Date of publication A2: |
|
26.08.2009 Bulletin 2009/35 |
| (22) |
Date of filing: 22.05.2003 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
| (30) |
Priority: |
22.05.2002 US 382446 P
22.05.2003 US 443419
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
03799809.3 / 1549953 |
| (71) |
Applicant: Platypus Technologies, Inc. |
|
Madison, WI 53719 (US) |
|
| (72) |
Inventors: |
|
- Murphy, Christopher
Madison, WI 53705 (US)
- Israel, Barbara
Mt. Horeb, WI 53572 (US)
- Abbott, Nicholas
Madison, WI 53711 (US)
|
| (74) |
Representative: Glawe, Delfs, Moll |
|
Patent- und Rechtsanwälte
Rothenbaumchaussee 58
20148 Hamburg
20148 Hamburg (DE) |
|
| |
|
| (54) |
Substrates, devices, and methods for cellular assays |
(57) The present invention relates to the field of molecular diagnostics, and in particular
to diagnostics based on a liquid crystal assay format. In particular, the present
invention provided improved substrates and methods of using liquid crystal assays
for quantitating the amount of an analyte in a sample. The present invention also
provides materials and methods for detecting non-specific binding of an analyte to
a substrate by using a liquid crystal assay format.